Newswise — April 23, 2021 – Wolters Kluwer, Health announced today the publication of two new, fully open access journals under its Lippincott® portfolio as part of an ongoing collaboration with the Chinese Medical Association (CMA). Cardiology Discovery and Infectious Diseases & Immunity will accelerate the dissemination, exchange, and utilization of scientific research results in their respective fields.

“We are excited to expand our relationship with the Chinese Medical Association in launching these new open access journals that will provide dedicated spaces for important research in cardiovascular medicine and infectious diseases,” said Jennifer Brogan, Vice President, Journal Publishing & Society Solutions at Wolters Kluwer, Health Learning, Research & Practice. “Wolters Kluwer is focused on expanding the open access titles available to professionals in all areas of medicine and these two journals are important additions to the Lippincott portfolio.”

Cardiology Discovery (CD) will publish high-quality materials on all aspects of cardiovascular medicine and surgery, including: original clinical, epidemiological, basic and translational research; health services and outcomes studies; state-of-the-art reviews; technical evaluations; case reports; editorial, perspective, consensus and guideline papers. The mission of CD is to create a platform of international collaboration and exchange of cutting-edge information on cardiovascular research and education.

Infectious Diseases & Immunity (IDI) will focus on new developments in basic and clinical research in the diagnosis and treatment of infectious diseases and related immunology. The journal aims to provide a platform of timely academic exchanges and information transmission for scientists and clinical experts in related fields around the world.​

“We look forward to working with Wolters Kluwer in publishing these new journals and delivering translational research related to cardiology and infectious diseases to medical professionals worldwide,” said Jun-Min Wei, the president and editor-in-chief of Chinese Medical Association Publishing House. “The global reach of Wolters Kluwer in medical and allied healthcare publishing will support the goals of the CMAPH.”

###

About the Chinese Medical Association

Chinese Medical Association (CMA) is a non-profit national academic organization in China. It is an important social force in the development of medical science and technology and a connection between government and medical professionals. Established in 1915, CMA now has 88 specialty societies and 677,000 members in China.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit www.wolterskluwer.com, follow us on TwitterFacebookLinkedIn, and YouTube.

SEE ORIGINAL STUDY